Related Experiment Videos
[1st experience with Solutrast, a new contrast medium for myelography]
Rontgen-Blatter; Zeitschrift Fur Rontgen-Technik Und Medizinisch-Wissenschaftliche Photographie
|January 1, 1983
Summary
The new contrast medium Lopamidol (Solutrast) demonstrated excellent tolerability and safety in 150 myelographies. It provides faultless image quality for examining the entire vertebral canal.
Area of Science:
- Radiology
- Neuroradiology
- Medical Imaging
Background:
- Aqueous contrast media have been utilized for myelography.
- Evaluating new contrast agents is crucial for improving diagnostic accuracy and patient safety.
Purpose of the Study:
- To evaluate the safety and efficacy of Lopamidol (Solutrast) in myelography.
- To assess the image quality and tolerability of Lopamidol for examining the entire vertebral canal.
Main Methods:
- Conducted a survey of myelographic results with aqueous contrast media.
- Performed 150 myelographies using the new contrast medium, Lopamidol (Solutrast).
- Assessed patient tolerance, risk factors, and image quality.
Main Results:
- Lopamidol (Solutrast) was found to be very well tolerated in patients.
- The use of Lopamidol involved a low risk profile.
- Image quality obtained with Lopamidol was consistently faultless.
- The contrast medium is suitable for examining the entire vertebral canal.
Conclusions:
- Lopamidol (Solutrast) is a safe and effective contrast medium for myelography.
- It offers excellent tolerability and diagnostic image quality.
- Recommended for comprehensive examination of the vertebral canal.